• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
A phase II trial of eltrombopag for patients with chronic lymphocytic leukaemia (CLL) and thrombocytopenia.艾曲泊帕用于慢性淋巴细胞白血病（CLL）和血小板减少症患者的II期试验。
Br J Haematol. 2019 May;185(3):606-608. doi: 10.1111/bjh.15581. Epub 2018 Nov 8.
2
A pilot phase I dose finding safety study of the thrombopoietin-receptor agonist, eltrombopag, in patients with myelodysplastic syndrome treated with azacitidine.一项关于血小板生成素受体激动剂艾曲泊帕在接受阿扎胞苷治疗的骨髓增生异常综合征患者中的I期剂量探索性安全性试验。
Eur J Haematol. 2014 Nov;93(5):439-45. doi: 10.1111/ejh.12383. Epub 2014 Jun 14.
3
Usefulness of eltrombopag for treating thrombocytopenia after allogeneic stem cell transplantation.艾曲泊帕用于治疗异基因造血干细胞移植后血小板减少症的有效性
Bone Marrow Transplant. 2019 May;54(5):757-761. doi: 10.1038/s41409-018-0368-1. Epub 2018 Oct 24.
4
Eltrombopag for thrombocytopenia following allogeneic hematopoietic stem cell transplantation in children.儿童异基因造血干细胞移植后血小板减少症的艾曲波帕治疗。
Pediatr Blood Cancer. 2020 May;67(5):e28208. doi: 10.1002/pbc.28208. Epub 2020 Feb 17.
5
Efficacy and safety of eltrombopag in Japanese patients with chronic liver disease and thrombocytopenia: a randomized, open-label, phase II study.在日本患有慢性肝脏疾病和血小板减少症的患者中，艾曲波帕的疗效和安全性：一项随机、开放标签、2 期研究。
J Gastroenterol. 2012 Dec;47(12):1342-51. doi: 10.1007/s00535-012-0600-5. Epub 2012 Jun 8.
6
Molecule of the month. Eltrombopag.本月分子。艾曲泊帕。
Drug News Perspect. 2008 Jul-Aug;21(6):344.
7
Eltrombopag named patient programme for patients with chronic immune thrombocytopenia.艾曲泊帕针对慢性免疫性血小板减少症患者的命名患者计划。
Br J Haematol. 2012 Apr;157(2):259-60. doi: 10.1111/j.1365-2141.2011.08954.x. Epub 2011 Nov 17.
8
Results of a phase I dose escalation study of eltrombopag in patients with advanced soft tissue sarcoma receiving doxorubicin and ifosfamide.在接受多柔比星和异环磷酰胺治疗的晚期软组织肉瘤患者中进行的依鲁替尼剂量递增研究的结果。
BMC Cancer. 2013 Mar 16;13:121. doi: 10.1186/1471-2407-13-121.
9
Oral eltrombopag for up to three years is safe and well-tolerated in Japanese patients with previously treated chronic immune thrombocytopenia: an open-label, extension study.口服艾曲波帕治疗日本既往治疗的慢性免疫性血小板减少症患者长达 3 年，安全性和耐受性良好：一项开放标签扩展研究。
Int J Hematol. 2013 Sep;98(3):323-30. doi: 10.1007/s12185-013-1401-1. Epub 2013 Jul 30.
10
Thrombopoietin receptor agonists to control immune thrombocytopenia in patients with active lymphoma.血小板生成素受体激动剂用于控制活动性淋巴瘤患者的免疫性血小板减少症。
Br J Haematol. 2019 Sep;186(6):e217-e219. doi: 10.1111/bjh.16114. Epub 2019 Jul 31.

引用本文的文献

1
IGF-1 and IGF-2 as Molecules Linked to Causes and Consequences of Obesity from Fetal Life to Adulthood: A Systematic Review.IGF-1 和 IGF-2 作为与胎儿期到成年期肥胖的原因和后果相关的分子：系统评价。
Int J Mol Sci. 2024 Apr 2;25(7):3966. doi: 10.3390/ijms25073966.
2
Off-Label Use of Thrombopoietin Receptor Agonists: Case Series and Review of the Literature.血小板生成素受体激动剂的超说明书用药：病例系列及文献综述
Front Oncol. 2021 Sep 28;11:680411. doi: 10.3389/fonc.2021.680411. eCollection 2021.
3
How I manage autoimmune cytopenias in patients with lymphoid cancer.我如何治疗淋巴癌患者的自身免疫性血细胞减少症。
Blood. 2022 Mar 10;139(10):1479-1488. doi: 10.1182/blood.2019003686.
4
Autoimmune Cytopenias in Chronic Lymphocytic Leukemia: Focus on Molecular Aspects.慢性淋巴细胞白血病中的自身免疫性血细胞减少症：聚焦分子层面
Front Oncol. 2020 Jan 10;9:1435. doi: 10.3389/fonc.2019.01435. eCollection 2019.
5
A Concise Review of Autoimmune Cytopenias in Chronic Lymphocytic Leukemia.慢性淋巴细胞白血病中自身免疫性血细胞减少症的简要综述
Curr Hematol Malig Rep. 2017 Feb;12(1):29-38. doi: 10.1007/s11899-017-0366-1.
6
Alternatives, and adjuncts, to prophylactic platelet transfusion for people with haematological malignancies undergoing intensive chemotherapy or stem cell transplantation.对于接受强化化疗或干细胞移植的血液系统恶性肿瘤患者，预防性血小板输注的替代方法和辅助措施。
Cochrane Database Syst Rev. 2016 Aug 22;2016(8):CD010982. doi: 10.1002/14651858.CD010982.pub2.

本文引用的文献

1
A Concise Review of Autoimmune Cytopenias in Chronic Lymphocytic Leukemia.慢性淋巴细胞白血病中自身免疫性血细胞减少症的简要综述
Curr Hematol Malig Rep. 2017 Feb;12(1):29-38. doi: 10.1007/s11899-017-0366-1.
2
Targeted therapies for CLL: Practical issues with the changing treatment paradigm.慢性淋巴细胞白血病的靶向治疗：治疗模式转变带来的实际问题
Blood Rev. 2016 May;30(3):233-44. doi: 10.1016/j.blre.2015.12.002. Epub 2015 Dec 24.
3
Chronic lymphocytic leukemia-associated refractory immune thrombocytopenia successfully treated with eltrombopag.艾曲泊帕成功治疗慢性淋巴细胞白血病相关难治性免疫性血小板减少症
Tumori. 2015 Apr 28;101(2):e49-50. doi: 10.5301/je.5000248.
4
Eltrombopag for resistant immune thrombocytopenia secondary to chronic lymphocytic leukaemia.艾曲泊帕用于慢性淋巴细胞白血病继发的难治性免疫性血小板减少症。
Intern Med J. 2014 Jul;44(7):697-9. doi: 10.1111/imj.12468.
5
Eltrombopag and improved hematopoiesis in refractory aplastic anemia.依鲁替尼改善再生障碍性贫血的造血功能。
N Engl J Med. 2012 Jul 5;367(1):11-9. doi: 10.1056/NEJMoa1200931.
6
Successful treatment with thrombopoietin receptor agonist in avoiding splenectomy for patients with chronic refractory immune thrombocytopenia.采用促血小板生成素受体激动剂治疗避免了慢性难治性免疫性血小板减少症患者行脾切除术。
Mediterr J Hematol Infect Dis. 2012;4(1):e2012003. doi: 10.4084/MJHID.2012.003. Epub 2012 Jan 18.
7
Eltrombopag, a second-generation thrombopoietin receptor agonist, for chronic lymphocytic leukemia-associated ITP.
Leukemia. 2010 May;24(5):1096-8. doi: 10.1038/leu.2010.45. Epub 2010 Mar 25.
8
Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura.艾曲波帕用于治疗慢性特发性血小板减少性紫癜。
N Engl J Med. 2007 Nov 29;357(22):2237-47. doi: 10.1056/NEJMoa073275.
9
Eltrombopag for thrombocytopenia in patients with cirrhosis associated with hepatitis C.艾曲泊帕用于丙型肝炎相关肝硬化患者的血小板减少症
N Engl J Med. 2007 Nov 29;357(22):2227-36. doi: 10.1056/NEJMoa073255.
10
Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia.国际工作组（IWG）骨髓增生异常综合征反应标准的临床应用及修订建议
Blood. 2006 Jul 15;108(2):419-25. doi: 10.1182/blood-2005-10-4149. Epub 2006 Apr 11.

A phase II trial of eltrombopag for patients with chronic lymphocytic leukaemia (CLL) and thrombocytopenia.

作者信息

Paul Shilpa, Jain Nitin, Ferrajoli Alessandra, O'Brien Susan, Burger Jan, Keating Michael, Wierda William

机构信息

Division of Pharmacy, the University of Texas, MD Anderson Cancer Center, Houston, TX, USA.

Department of Leukemia, the University of Texas, MD Anderson Cancer Center, Houston, TX, USA.

出版信息

Br J Haematol. 2019 May;185(3):606-608. doi: 10.1111/bjh.15581. Epub 2018 Nov 8.

DOI:10.1111/bjh.15581
PMID:30406944
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11770971/
Abstract
摘要